Therefore, our study was aimed to investigate the changes in circulating levels of arachidonic acid, IL-6, and CRP in patients with FluA, RSV, or COVID-19, and to analyze the potential of these parameters as diagnosis of prognosis biomarkers. The gene discussed is CRP; the disease is COVID-19.